Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  MEDNAX Inc    MD

Delayed Quote. Delayed  - 07/22 10:02:01 pm
75.91 USD   +0.12%
07/14 MEDNAX : 2016 Second Quarter Conference Call/Webcast Scheduled for T..
07/12 MEDNAX : to Exhibit at the 24th Annual Health Forum and the American..
07/11 MEDNAX : Announces Acquisition of Cardiology Practice in Virginia
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Sales2 1542 439-3 1613 4723 950
Operating income (EBITDA)492559654693760881
Operating profit (EBIT)452513632608672762
Pre-Tax Profit (EBT)448-----
Net income281317-349387433
P/E ratio19,220,820,020,318,316,5
EPS ( $ )2,783,183,583,734,144,60
Dividend per Share ( $ )------
Yield------
Reference price ( $ )53.3866.1171.6675.9175.9175.91
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
----
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Debt-515-1 221980-
Finance10,4-----
Operating income (EBITDA)492559654693760881
Leverage
(Debt/EBITDA)
-0,92x-1,76x1,29x-
Capital Expenditure15,618,127,137,030,835,0
Book Value Per Share (BVPS)23,2 $22,6 $25,9 $29,2 $32,4 $34,8 $
Cash Flow per Share4,02 $4,23 $3,92 $5,32 $5,66 $5,80 $
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 7 053 M$ -
Entreprise Value (EV) 8 274 M$ 8 033 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 20,3x 18,3x
Capitalization / Revenue 2,23x 2,03x
EV / Revenue 2,62x 2,31x
EV / EBITDA 11,9x 10,6x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,60x 2,35x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,2% 19,4%
operating Leverage (Delta EBIT / Delta Sales) - 1,07x
Net Margin (Net Profit / Revenue) 11,0% 11,2%
ROA (Net Profit / Asset) 7,40% 7,60%
ROE (Net Profit / Equities) 14,0% 13,8%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   1,17% 0,89%
Cash Flow / Sales 15,6% 15,1%
Capital Intensity (Assets / Sales) 1,49x 1,47x
Financial Leverage (Net Debt / EBITDA) 1,76x 1,29x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend